{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:56:47Z","timestamp":1790963807128,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Histology plays an essential role in therapeutic decision-making for lung cancer patients. However, the molecular determinants of lung cancer histology are largely unknown. We conduct whole-exome sequencing and microarray profiling on 19 micro-dissected tumor regions of different histologic subtypes from 9 patients with lung cancers of mixed histology. A median of 68.9% of point mutations and 83% of copy number aberrations are shared between different histologic components within the same tumors. Furthermore, different histologic components within the tumors demonstrate similar subclonal architecture. On the other hand, transcriptomic profiling reveals shared pathways between the same histologic subtypes from different patients, which is supported by the analyses of the transcriptomic data from 141 cell lines and 343 lung cancers of different histologic subtypes. These data derived from mixed histologic subtypes in the setting of identical genetic background and exposure history support that the histologic fate of lung cancer cells is associated with transcriptomic features rather than the genomic profiles in most tumors.<\/jats:p>","DOI":"10.1038\/s41467-021-27341-1","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T06:06:05Z","timestamp":1638770765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics"],"prefix":"10.1038","volume":"12","author":[{"given":"Ming","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-3562","authenticated-orcid":false,"given":"Hussein A.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8938-6699","authenticated-orcid":false,"given":"Marcelo V.","family":"Negrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheshwari","family":"Ramineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7907-9609","authenticated-orcid":false,"given":"Shawna Marie","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4510-0382","authenticated-orcid":false,"given":"Alexandre","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5412-9860","authenticated-orcid":false,"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Wan","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizeng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8392-8338","authenticated-orcid":false,"given":"Jia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latasha","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Gumbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-5713","authenticated-orcid":false,"given":"Cesar","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annikka","family":"Weissferdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5469-9214","authenticated-orcid":false,"given":"J. Jack","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Sepesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3080-1920","authenticated-orcid":false,"given":"Stephen","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-3417","authenticated-orcid":false,"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-8719","authenticated-orcid":false,"given":"Jonathan","family":"Kurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2362-3094","authenticated-orcid":false,"given":"Don","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9068-8942","authenticated-orcid":false,"given":"John V.","family":"Heymach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio I.","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-2671","authenticated-orcid":false,"given":"P. Andrew","family":"Futreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-6435","authenticated-orcid":false,"given":"Neda","family":"Kalhor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-3477","authenticated-orcid":false,"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"27341_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"27341_CR2","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.6004\/jnccn.2019.0059","volume":"17","author":"DS Ettinger","year":"2019","unstructured":"Ettinger, D. S. et al. NCCN guidelines insights: non\u2013small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines. J. Natl Compr. Canc. Netw. 17, 1464\u20131472 (2019).","journal-title":"J. Natl Compr. Canc. Netw."},{"key":"27341_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jcp.47.8.711","volume":"47","author":"RA Burnett","year":"1994","unstructured":"Burnett, R. A. et al. Observer variability in histopathological reporting of malignant bronchial biopsy specimens. J. Clin. Pathol. 47, 711\u2013713 (1994).","journal-title":"J. Clin. Pathol."},{"key":"27341_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5858\/arpa.2012-0033-OA","volume":"137","author":"JE Grilley-Olson","year":"2013","unstructured":"Grilley-Olson, J. E. et al. Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets. Arch. Pathol. Lab. Med. 137, 32\u201340 (2013).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"27341_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13200","volume":"7","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Genomic heterogeneity of multiple synchronous lung cancer. Nat. Commun. 7, 13200 (2016).","journal-title":"Nat. Commun."},{"key":"27341_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1256930","volume":"346","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256\u2013259 (2014).","journal-title":"Science"},{"key":"27341_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S1010-7940(02)00481-5","volume":"22","author":"E Ruffini","year":"2002","unstructured":"Ruffini, E. et al. Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance. Eur. J. Cardiothorac. Surg. 22, 701\u2013707 (2002).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"27341_CR8","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.athoracsur.2012.12.037","volume":"95","author":"P Mordant","year":"2013","unstructured":"Mordant, P. et al. Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implications. Ann. Thorac. Surg. 95, 1189\u20131195 (2013).","journal-title":"Ann. Thorac. Surg."},{"key":"27341_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0304-3835(95)03931-L","volume":"96","author":"WG Hammond","year":"1995","unstructured":"Hammond, W. G., Tesluk, H. & Benfield, J. R. Histogenesis of adenosquamous bronchogenic carcinoma. Cancer Lett. 96, 163\u2013168 (1995).","journal-title":"Cancer Lett."},{"key":"27341_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/cncr.22413","volume":"109","author":"SM Kang","year":"2007","unstructured":"Kang, S. M. et al. Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung. Cancer 109, 581\u2013587 (2007).","journal-title":"Cancer"},{"key":"27341_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1309\/AJCP08IQZAOGYLFL","volume":"135","author":"N Tochigi","year":"2011","unstructured":"Tochigi, N., Dacic, S., Nikiforova, M., Cieply, K. M. & Yousem, S. A. Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population. Am. J. Clin. Pathol. 135, 783\u2013789 (2011).","journal-title":"Am. J. Clin. Pathol."},{"key":"27341_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1053\/j.semdp.2014.06.004","volume":"31","author":"N Rao","year":"2014","unstructured":"Rao, N. Adenosquamous carcinoma. Semin. Diagn. Pathol. 31, 271\u2013277 (2014).","journal-title":"Semin. Diagn. Pathol."},{"key":"27341_CR13","doi-asserted-by":"publisher","first-page":"914","DOI":"10.5858\/arpa.2017-0584-RA","volume":"142","author":"AC Borczuk","year":"2018","unstructured":"Borczuk, A. C. Uncommon types of lung carcinoma with mixed histology: sarcomatoid carcinoma, adenosquamous carcinoma, and mucoepidermoid carcinoma. Arch. Pathol. Lab. Med. 142, 914\u2013921 (2018).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"27341_CR14","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.2147\/OTT.S164574","volume":"11","author":"C Li","year":"2018","unstructured":"Li, C. & Lu, H. Adenosquamous carcinoma of the lung. Onco. Targets Ther. 11, 4829\u20134835 (2018).","journal-title":"Onco. Targets Ther."},{"key":"27341_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"27341_CR16","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1073\/pnas.191502998","volume":"98","author":"A Bhattacharjee","year":"2001","unstructured":"Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl Acad. Sci. USA. 98, 13790\u201313795 (2001).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"27341_CR17","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jtho.2017.05.008","volume":"12","author":"A Karlsson","year":"2017","unstructured":"Karlsson, A. et al. Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological WHO 2015 classification. J. Thorac. Oncol. 12, 1257\u20131267 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"27341_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"27341_CR19","doi-asserted-by":"crossref","unstructured":"Lee, W.-C. et al. Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity. Genome Biol. 21, 271 (2020).","DOI":"10.1186\/s13059-020-02175-0"},{"key":"27341_CR20","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","volume":"376","author":"M Jamal-Hanjani","year":"2017","unstructured":"Jamal-Hanjani, M. et al. Tracking the evolution of non\u2013small-cell lung cancer. N. Engl. J. Med. 376, 2109\u20132121 (2017).","journal-title":"N. Engl. J. Med."},{"key":"27341_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nmeth.2883","volume":"11","author":"A Roth","year":"2014","unstructured":"Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396\u2013398 (2014).","journal-title":"Nat. Methods"},{"key":"27341_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal. Cell 173, 581\u2013594.e12 (2018).","journal-title":"Cell"},{"key":"27341_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1775-1","volume":"576","author":"FP Barthel","year":"2019","unstructured":"Barthel, F. P. et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576, 112\u2013120 (2019).","journal-title":"Nature"},{"key":"27341_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.3564","volume":"48","author":"JD Campbell","year":"2016","unstructured":"Campbell, J. D. et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat. Genet. 48, 607\u2013616 (2016).","journal-title":"Nat. Genet."},{"key":"27341_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","volume":"489","author":"The Cancer Genome Atlas Research Network","year":"2012","unstructured":"The Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519\u2013525 (2012).","journal-title":"Nature"},{"key":"27341_CR26","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ng.2396","volume":"44","author":"M Peifer","year":"2012","unstructured":"Peifer, M. et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet. 44, 1104\u20131110 (2012).","journal-title":"Nat. Genet."},{"key":"27341_CR27","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"27341_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng.3774","volume":"49","author":"M Griffith","year":"2017","unstructured":"Griffith, M. et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat. Genet. 49, 170\u2013174 (2017).","journal-title":"Nat. Genet."},{"key":"27341_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ng.2891","volume":"46","author":"M Gerlinger","year":"2014","unstructured":"Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46, 225\u2013233 (2014).","journal-title":"Nat. Genet."},{"key":"27341_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10877-8","volume":"10","author":"X Hu","year":"2019","unstructured":"Hu, X. et al. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat. Commun. 10, 2978 (2019).","journal-title":"Nat. Commun."},{"key":"27341_CR31","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41379-018-0029-3","volume":"31","author":"W-C Lee","year":"2018","unstructured":"Lee, W.-C. et al. Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer. Mod. Pathol. 31, 947\u2013955 (2018).","journal-title":"Mod. Pathol."},{"key":"27341_CR32","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/JTO.0000000000000589","volume":"10","author":"M Fasano","year":"2015","unstructured":"Fasano, M., Della Corte, C. M., Papaccio, F., Ciardiello, F. & Morgillo, F. Pulmonary large-cell neuroendocrine carcinoma: from epidemiology to therapy. J. Thorac. Oncol. 10, 1133\u20131141 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"27341_CR33","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"27341_CR34","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi, L. et al. Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer. N. Engl. J. Med. 378, 2078\u20132092 (2018).","journal-title":"N. Engl. J. Med."},{"key":"27341_CR35","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","volume":"379","author":"L Paz-Ares","year":"2018","unstructured":"Paz-Ares, L. et al. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N. Engl. J. Med. 379, 2040\u20132051 (2018).","journal-title":"N. Engl. J. Med."},{"key":"27341_CR36","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","volume":"379","author":"L Horn","year":"2018","unstructured":"Horn, L. et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N. Engl. J. Med. 379, 2220\u20132229 (2018).","journal-title":"N. Engl. J. Med."},{"key":"27341_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrclinonc.2015.90","volume":"12","author":"A Thomas","year":"2015","unstructured":"Thomas, A., Liu, S. V., Subramaniam, D. S. & Giaccone, G. Refining the treatment of NSCLC according to histological and molecular subtypes. Nat. Rev. Clin. Oncol. 12, 511\u2013526 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"27341_CR38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"The Cancer Genome Atlas Research Network","year":"2014","unstructured":"The Cancer Genome Atlas Research Network Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543\u2013550 (2014).","journal-title":"Nature"},{"key":"27341_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/JTO.0b013e3181f94abb","volume":"6","author":"T-H Shiao","year":"2011","unstructured":"Shiao, T.-H. et al. Epidermal growth factor receptor mutations in small cell lung cancer: a brief report. J. Thorac. Oncol. 6, 195\u2013198 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"27341_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cllc.2018.08.020","volume":"20","author":"VK Lam","year":"2019","unstructured":"Lam, V. K. et al. Targeted tissue and cell-free tumor DNA sequencing of advanced lung squamous-cell carcinoma reveals clinically significant prevalence of actionable alterations. Clin. Lung Cancer 20, 30\u201336.e3 (2019).","journal-title":"Clin. Lung Cancer"},{"key":"27341_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7377","volume":"6","author":"MJ Niederst","year":"2015","unstructured":"Niederst, M. J. et al. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer. Nat. Commun. 6, 6377 (2015).","journal-title":"Nat. Commun."},{"key":"27341_CR42","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1200\/JCO.2016.71.9096","volume":"35","author":"J-K Lee","year":"2017","unstructured":"Lee, J.-K. et al. Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas. J. Clin. Oncol. 35, 3065\u20133074 (2017).","journal-title":"J. Clin. Oncol."},{"key":"27341_CR43","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1158\/1078-0432.CCR-10-0199","volume":"16","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. et al. Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin. Cancer Res. 16, 4864\u20134875 (2010).","journal-title":"Clin. Cancer Res."},{"key":"27341_CR44","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/bjc.2014.402","volume":"111","author":"A Warth","year":"2014","unstructured":"Warth, A. et al. Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role. Br. J. Cancer 111, 1222\u20131229 (2014).","journal-title":"Br. J. Cancer"},{"key":"27341_CR45","unstructured":"George, J. et al. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nat. Commun. 9, 1048 (2018)."},{"key":"27341_CR46","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S1470-2045(16)30098-5","volume":"17","author":"SJ Antonia","year":"2016","unstructured":"Antonia, S. J. et al. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1\/2 trial. Lancet Oncol. 17, 883\u2013895 (2016).","journal-title":"Lancet Oncol."},{"key":"27341_CR47","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis, W. D., Brambilla, E., Burke, A. P., Marx, A. & Nicholson, A. G. Introduction to the 2015 world health organization classification of tumors of the lung, pleura, thymus, and heart. J. Thorac. Oncol. 10, 1240\u20131242 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"27341_CR48","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1158\/1078-0432.CCR-19-0556","volume":"26","author":"M Zhuo","year":"2020","unstructured":"Zhuo, M. et al. The prognostic and therapeutic role of genomic subtyping by sequencing tumor or cell-free DNA in pulmonary large-cell neuroendocrine carcinoma. Clin. Cancer Res. 26, 892\u2013901 (2020).","journal-title":"Clin. Cancer Res."},{"key":"27341_CR49","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis, W. D. et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10, 1243\u20131260 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"27341_CR50","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/00000478-200209000-00009","volume":"26","author":"SA Nicholson","year":"2002","unstructured":"Nicholson, S. A. et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am. J. Surg. Pathol. 26, 1184\u20131197 (2002).","journal-title":"Am. J. Surg. Pathol."},{"key":"27341_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.thorsurg.2014.04.001","volume":"24","author":"WD Travis","year":"2014","unstructured":"Travis, W. D. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine. Thorac. Surg. Clin. 24, 257\u2013266 (2014).","journal-title":"Thorac. Surg. Clin."},{"key":"27341_CR52","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at arXiv [q-bio.GN] (2013)."},{"key":"27341_CR53","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"27341_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s42003-018-0023-9","volume":"1","author":"G Narzisi","year":"2018","unstructured":"Narzisi, G. et al. Genome-wide somatic variant calling using localized colored de Bruijn graphs. Commun. Biol. 1, 20 (2018).","journal-title":"Commun. Biol."},{"key":"27341_CR55","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway, J. R., Lex, A. & Gehlenborg, N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33, 2938\u20132940 (2017).","journal-title":"Bioinformatics"},{"key":"27341_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."},{"key":"27341_CR57","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/bioinformatics\/btq706","volume":"27","author":"KP Schliep","year":"2011","unstructured":"Schliep, K. P. phangorn: phylogenetic analysis in R. Bioinformatics 27, 592\u2013593 (2011).","journal-title":"Bioinformatics"},{"key":"27341_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0539-0","volume":"10","author":"F Blokzijl","year":"2018","unstructured":"Blokzijl, F., Janssen, R., van Boxtel, R. & Cuppen, E. MutationalPatterns: comprehensive genome-wide analysis of mutational processes. Genome Med. 10, 33 (2018).","journal-title":"Genome Med."},{"key":"27341_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jmoldx.2014.09.008","volume":"17","author":"C Grasso","year":"2015","unstructured":"Grasso, C. et al. Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data. J. Mol. Diagn. 17, 53\u201363 (2015).","journal-title":"J. Mol. Diagn."},{"key":"27341_CR60","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"27341_CR61","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"27341_CR62","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","volume":"26","author":"BS Carvalho","year":"2010","unstructured":"Carvalho, B. S. & Irizarry, R. A. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26, 2363\u20132367 (2010).","journal-title":"Bioinformatics"},{"key":"27341_CR63","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"27341_CR64","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis, S. & Meltzer, P. S. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 23, 1846\u20131847 (2007).","journal-title":"Bioinformatics"},{"key":"27341_CR65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy\u2014analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"},{"key":"27341_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"27341_CR67","doi-asserted-by":"publisher","unstructured":"Korotkevich, G., Sukhov, V. & Sergushichev, A. Fast gene set enrichment analysis. Cold Spring Harbor Laboratory. 060012 https:\/\/doi.org\/10.1101\/060012 (2019).","DOI":"10.1101\/060012"},{"key":"27341_CR68","doi-asserted-by":"publisher","unstructured":"Tang, M. The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics crazyhottommy\/mixed_histology_lung_cancer: Release v0.1.0. Zenodo. https:\/\/doi.org\/10.5281\/ZENODO.5595490 (2021).","DOI":"10.5281\/ZENODO.5595490"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27341-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27341-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27341-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T14:10:43Z","timestamp":1669990243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27341-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["27341"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27341-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,6]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the PDF version of this article, the equal contribution of Ming Tang and Hussein A. Abbas affiliation was incorrectly denoted as 14. The correction number is 11. The PDF has now been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jianjun Zhang reports research funding from Merck, Johnson and Johnson, and consultant fees from BMS, Johnson and Johnson, AstraZeneca, Geneplus, OrigMed, Innovent outside the submitted work. J. V. H. reports research funding from AstraZeneca, GlaxoSmithKline, and Spectrum; consultant fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Catalyst, EMD Serono, Foundation Medicine, Hengrui Therapeutics, Genentech, GSK, Guardant Health, Eli Lilly, Merck, Novartis, Pfizer, Roche, Sanofi, Seattle Genetics, Spectrum, and Takeda; licensing fees from Spectrum. B. S. reports consultant fees from BMS. M. V. N. reports research funding from Mirati, Novartis, Checkmate, Ziopharm, AstraZeneca, Pfizer, and Genentech; consultant fees from Mirati, Merck\/MSD. The other authors declare neither financial nor non-financial interests in the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7081"}}